Oral Anti-Cancer Drug (OACD) Fees
OACDs meet the requirements for coverage under the Omnibus Budget Reconciliation Act of 1993 (OBRA '93) and are billed using the National Drug Code (NDC) when submitted to the Durable Medical Equipment Medicare Administrative Contractors (DME MAC). Fees for OACDs are subject to change on a quarterly basis.
The creation and maintenance of Quarterly OACD fee files by the PDAC has been discontinued due to claims payment system modernization and enhancement efforts. To identify applicable fees for OACDs please reference the appropriate Average Sales Price (ASP) pricing files on CMS’s website for the specific drug information and fees.
View archived OACD Update files
| Year | Quarter |
|---|---|
| 2026 | Quarter 3 - Updated June 24, 2026 Quarter 2 - Updated March 24, 2026 Quarter 1 - Updated December 23, 2025 |
| 2025 |
Quarter 4 - Updated September 23, 2025 |
| 2024 |
Quarter 4 - Updated September 25, 2024 |
| 2023 |
Quarter 4 - Updated September 21, 2023 |
| 2022 |
Quarter 4 - Updated September 27, 2022 |
| 2021 |
Quarter 4 - Updated September 20, 2021 |
Oral Anti-Cancer Drug (OACD) Fees Articles
| There are no articles under this category. |